High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis
NCT01603199 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2016-06-08
Summary
Primary biliary cirrhosis is a chronic cholestatic autoimmune liver disease with a progressive course that can lead to liver cirrhosis. There are few studies on dietary management in primary biliary cirrhosis and most of them have focused on micronutrients specifically vitamin D intake to prevent osteoporosis, and lipid control to prevent hyperlipidemia, but few recommendations have been made regarding a complete dietary approach. Fiber has been proven to increase the excretion of nitrogen products and consequently reduce its blood levels, and an adequate protein intake (1- 1.5 g per kg) has shown to decrease endogenous catabolism in cirrhotic patients.
The purpose of this study is to evaluate the impact of a high-protein, high-fiber diet in the nutritional status of patients with primary biliary cirrhosis.
Conditions
- Primary Biliary Cirrhosis
Interventions
- DIETARY_SUPPLEMENT
-
High protein high fiber diet
A personalized high protein high fiber dietary plan will be provided to each participant from both groups. Each participant will receive nutritional counseling once a month during six months.
Sponsors & Collaborators
-
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
lead OTHER
Principal Investigators
-
Aldo Torre Delgadillo, M.D. M.Sc · INCMNSZ
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2015-07-31
- Completion
- 2016-06-30
Countries
- Mexico
Study Locations
More Related Trials
-
Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders
NCT02937012 ·Status: UNKNOWN ·Phase: PHASE3
-
Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis
NCT01614405 ·Status: TERMINATED ·Phase: NA
-
Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis
NCT01688024 ·Status: UNKNOWN ·Phase: PHASE2
-
Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
NCT02400216 ·Status: COMPLETED
-
Primary Sclerosing Cholangitis in Children
NCT04181138 ·Status: RECRUITING
-
Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis
NCT03516006 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
NCT02230683 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis
NCT00393185 ·Status: WITHDRAWN ·Phase: PHASE1
-
Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis
NCT03069339 ·Status: UNKNOWN ·Phase: NA
-
Probiotics in the Prevention of Hepatocellular Carcinoma in Cirrhosis
NCT03853928 ·Status: UNKNOWN ·Phase: NA
-
Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis
NCT02135536 ·Status: COMPLETED ·Phase: PHASE2
-
Early Primary Prophylaxis of Esophageal Varices
NCT01196507 ·Status: COMPLETED ·Phase: NA
-
EXerCise Intervention in cholesTatic LivEr Disease: The EXCITED Study
NCT04265235 ·Status: TERMINATED ·Phase: NA
-
A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)
NCT07229911 ·Status: RECRUITING ·Phase: PHASE1
-
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
NCT02932449 ·Status: COMPLETED
-
Clinical Research of Tapering UDCA in PBC Patients With a Complete Response
NCT04650243 ·Status: RECRUITING ·Phase: PHASE4
-
Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
NCT05045482 ·Status: RECRUITING ·Phase: PHASE1
-
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study
NCT06755541 ·Status: RECRUITING ·Phase: PHASE3
-
Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody
NCT01430429 ·Status: TERMINATED ·Phase: PHASE2
-
Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
NCT05751967 ·Status: RECRUITING ·Phase: PHASE3
-
Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis
NCT03668145 ·Status: UNKNOWN ·Phase: NA
-
Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
NCT06905054 ·Status: RECRUITING ·Phase: PHASE2
-
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
NCT02026401 ·Status: COMPLETED ·Phase: PHASE2
-
Ursodiol-Methotrexate for Primary Biliary Cirrhosis
NCT00006168 ·Status: COMPLETED ·Phase: PHASE3
-
Probiotics in NASH Patients - PROBILIVER TRIAL
NCT03467282 ·Status: UNKNOWN ·Phase: NA